Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA7 | P43166 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 8/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.41 |
| ▸ | CYP1A1 | P04798 | 7/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 7/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | ERN1 | O75460 | 1/20 | 0.38 |
| ▸ | NQO2 | P16083 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.36 |
| ▸ | CYP2E1 | P05181 | 2/20 | 0.36 |
| ▸ | CYP2C8 | P10632 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2886444 | 0.86 | ALDH1A1 (0.46) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL180252 | 0.80 | ALDH1A1 (0.50) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL15094975 | 0.79 | ALDH1A1 (0.43) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL25053617 | 0.78 | CA12 (0.52) | ALDH1A1CA12CA1CA2CA7 | |
| Bromide SCHEMBL20424457 | 0.78 | ALDH1A1 (0.48) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL31325535 | 0.78 | ALDH1A1 (0.48) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL6754210 | 0.76 | ALDH1A1 (0.46) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL8721590 | 0.74 | ALDH1A1 (0.43) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL8029761 | 0.73 | CA1 (0.50) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL8932161 | 0.73 | ALDH1A1 (0.42) | ALDH1A1CA12CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7250519-B2 | Method for the production of arylamines | MERCK PATENT GMBH (DE) | 2007-07-31 | — | — | US | disclosed |
| EP-1442007-B1 | METHOD FOR THE PRODUCTION OF ARYLAMINES | MERCK PATENT GMBH (DE) | 2006-11-29 | — | — | EP | disclosed |
| US-20050054854-A1 | Method for the production of arylamines | MERCK PATENT GMBH (DE) | 2005-03-10 | — | — | US | disclosed |
| EP-1442007-A1 | METHOD FOR THE PRODUCTION OF ARYLAMINES | Covion Organic Semiconductors GmbH (DE) | 2004-08-04 | — | — | EP | disclosed |
| WO-2003037844-A1 | METHOD FOR THE PRODUCTION OF ARYLAMINES | COVION ORGANIC SEMICONDUCTORS GMBH (DE) | 2003-05-08 | — | — | WO | disclosed |
| US-6084133-A | REACTING A PHOSPHINE HALIDE WITH A METAL, THEN PROTONATION RESULTING DIORGANO-SUBSTITUTED METAL PHOSPHIDE; SIMPLIFICATION, NONTOXIC, EFFICIENCY | KANKYO KAGAKU CENTER CO., LTD. (JP) | 2000-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050054854-A1 | Method for the production of arylamines | DDT, PDS5A, KMO | ALDH1A1 2177/4885CA12 2943/4885CA1 3320/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.